pemetrexed
Pemetrexed is a drug used to treat Non Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Mesothelioma, and other conditions. Pemetrexed is being actively studied in 190 studies and prior, has been studied in 213.
Top Sponsors | Top Sites | Top Investigators |
---|---|---|
Eli Lilly and Company | For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. | Si-Yu Wang |
Merck Sharp & Dohme Corp. | Research Site | Zhenyu Pan |
Hoffmann-La Roche | Asan Medical Center | Chang Jian Hua |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Active, not recruiting
- Chordoma
- Pemetrexed
- Santa Monica, CaliforniaJohn Wayne Cancer Institute
2022-03-08
Mar 8, 2022H
Recruiting
- Central Nervous System Lymphoma
- ICP-022
- Pemetrexed
- Zhengzhou, Henan, ChinaHenan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
2022-01-28
Jan 28, 2022B
M
Terminated
- Advanced Cancers
- Crizotinib (Xalkori)
- +2 more
- Houston, TexasUniversity of Texas MD Anderson Cancer Center
2021-09-03
Sep 3, 2021T
Recruiting
- Leptomeningeal Metastases
- Pemetrexed
- +3 more
- Changchun, Jilin, ChinaThe First Hospital of Jilin University
2022-03-17
Mar 17, 2022U
Recruiting
- Non-Small Cell Lung Cancer Metastatic
- Durvalumab
- +2 more
- Salt Lake City, UtahHuntsman Cancer Institute at University of Utah
2022-03-01
Mar 1, 2022S
Completed
- Lung Cancer
- Pemetrexed
- Gemcitabine
- Nashville, TennesseeTennessee Oncology
2022-02-21
Feb 21, 2022A
Recruiting
- Non Small Cell Lung Cancer
- +3 more
- Cabozantinib
- Pemetrexed
- Augusta, GeorgiaAugusta University Georgia Cancer Center
2022-03-06
Mar 6, 2022S
Completed
- Malignant Pleural Mesothelioma
- Non-Small Cell Lung Cancer
- BBI608
- +2 more
- Chiba, Japan
- +1 more
2021-09-05
Sep 5, 2021M
Recruiting
- Lung Cancer
- AMG 510
- +3 more
- Houston, TexasM D Anderson Cancer Center
2022-03-30
Mar 30, 2022N
Recruiting
- Carcinoma, Non-Small-Cell Lung
- +7 more
- Bosutinib
- Pemetrexed
- Augusta, GeorgiaAugusta University Georgia Cancer Center
2021-07-31
Jul 31, 2021R
Recruiting
- Non Small Cell Lung Cancer
- Mesothelioma
- Pemetrexed
- 's-Hertogenbosch, Netherlands
- +4 more
2021-09-14
Sep 14, 2021R
Recruiting
- Non Small Cell Lung Cancer
- Mesothelioma
- Pemetrexed
- 's-Hertogenbosch, Netherlands
- +4 more
2021-09-14
Sep 14, 2021R
Recruiting
- Non Small Cell Lung Cancer
- Mesothelioma
- Pemetrexed
- 's-Hertogenbosch, Netherlands
- +4 more
2021-09-14
Sep 14, 2021M
Recruiting
- Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant
- +6 more
- Avelumab
- Pemetrexed
- Houston, TexasM D Anderson Cancer Center
2021-11-17
Nov 17, 2021C
Completed
- Non-small Cell Lung Cancer
- Pemetrexed
- Chalon-sur-Saône, France
- +2 more
2021-05-21
May 21, 2021M
Active, not recruiting
- Mesothelioma
- Pembrolizumab
- +2 more
- Nishinomiya, Hyogo, Japan
- +3 more
2022-03-11
Mar 11, 2022N
Completed
- Brain and Central Nervous System Tumors
- +10 more
- Pemetrexed
- Chicago, IllinoisRobert H. Lurie Comprehensive Cancer Center at Northwestern Univ
2021-09-03
Sep 3, 2021T
Not yet recruiting
- Non-Small Cell Lung Cancer
- Tislelizumab
- +2 more
- Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute and Hospital
2022-03-01
Mar 1, 2022X
Recruiting
- Nonsquamous Non-Small Cell Lung Cancer
- Sintilimab
- +2 more
- Yichang, Hubei, ChinaDepartment of Medical Oncology, Central Hospital of Yichang City
2021-11-05
Nov 5, 2021T
Recruiting
- Advanced Lung Non-Small Cell Carcinoma
- Non-Small Cell Carcinoma of Lung, TNM Stage 4
- Granulocyte-Macrophage Colony-Stimulating Factor
- +4 more
- Boston, MassachusettsTufts Medical Center
2022-01-05
Jan 5, 2022N
Recruiting
- Non-squamous Non-small-cell Lung Cancer
- Cancer, Lung
- Pembrolizumab
- Pemetrexed
- Nagoya, Aichi, JapanNational Hospital Organization Nagoya Medical Center
2021-04-23
Apr 23, 2021N
Active, not recruiting
- NSCLC Stage IV
- NSCLC, Recurrent
- Carboplatin
- +3 more
- Chicago, Illinois
- +6 more
2022-02-16
Feb 16, 2022S
Recruiting
- Non-small Cell Lung Cancer
- Atezolizumab(Tecentriq)
- +5 more
- Seoul, Gangnamgu, Korea, Republic ofSamsung Medical Center
2021-12-27
Dec 27, 2021J
Not yet recruiting
- Non-squamous Non-small-cell Lung Cancer
- EGFR Activating Mutation
- Pembrolizumab
- +3 more
- Urayasu, Chiba, Japan
- +9 more
2022-02-17
Feb 17, 2022